Health services researcher at Vanderbilt Health Policy. Avid coffee drinker, investigator of drug policies & prices. RT not an endorsement. Opinions are mine.
jamanetwork.com/journals/jam...
Reposted by Stacie B. Dusetzina
jamanetwork.com/journals/jam...
Reposted by Stacie B. Dusetzina, David L. Anderson
onlinelibrary.wiley.com/share/author...
Reposted by Stacie B. Dusetzina
Reposted by Stacie B. Dusetzina
"Congress must now also exercise its oversight responsibilities to ensure repairs to FDAs current and future capabilities, infrastructure, human resources, and reputation begin as soon as possible."
Big deal coming from investors/companies.
www.nopatientleftbehind.org/evidence-bas...
Reposted by Stacie B. Dusetzina
www.nber.org/papers/w34524
via @florianederer.bsky.social
Reposted by Stacie B. Dusetzina
Reposted by Archon Fung, Richard S.J. Tol, Nicholas A. Christakis , and 22 more Archon Fung, Richard S.J. Tol, Nicholas A. Christakis, David Lazer, Will Jennings, Gordon Pennycook, Brendan Nyhan, Ken Caldeira, Stacie B. Dusetzina, Alistair Munro, Caroline Krafft, Jacob Montgomery, Benjamin Braun, Adam Bonica, Gerry Canavan, Daniel S. Goldberg, Karen Benjamin Guzzo, Paul Goldsmith-Pinkham, Brian Keegan, David C. Kimball, Andy Reisinger, Sam Kamin, Pepper D. Culpepper, Achim Kemmerling, Nathan P. Kalmoe
www.nber.org/papers/w34524
via @florianederer.bsky.social
Reposted by Suresh Venkatasubramanian, Scott L. Greer, Stacie B. Dusetzina , and 13 more Suresh Venkatasubramanian, Scott L. Greer, Stacie B. Dusetzina, Steve Peers, Esther K. Choo, Cathy N. Davidson, Melanie C. Green, Janet Murray, Scott A. Imberman, Michael D. McDonald, Erin O’Donnell, Mark Rice, Magda Teter, Stella M. Rouse, Dan Immergluck, Colin Woodard
Hunter syndrome: Boy with rare condition amazes doctors after world-first gene therapy share.google/POY4UXyNcBUL...
Reposted by Stacie B. Dusetzina, Nathan P. Kalmoe
www.insidehighered.com/news/governa...
Reposted by Stacie B. Dusetzina
www.mskcc.org/news/msk-res...
@dusetzinas.bsky.social
Reposted by Stacie B. Dusetzina, Christian E. Weller, David Darmofal
Republicans have tried to kill the ACA more than 70 times since 2010, and have never once had a plan for anything better.
Reposted by Stacie B. Dusetzina
Reposted by Stacie B. Dusetzina
Reposted by Stacie B. Dusetzina
Reposted by Stacie B. Dusetzina
www.science.org/content/arti...
Reposted by Stacie B. Dusetzina, Dana Howard
Guess what roundtables don't have? FACA requirements to occur in public with the opportunity for public comment.
We looked at trends in biologic drug prices after biosimilar competition.
Key takeaways: savings from biosimilars are substantial, but take longer to accrue than commonly seen with generic small molecules.
1/
jamanetwork.com/journals/jam...
Reposted by Stacie B. Dusetzina
We looked at trends in biologic drug prices after biosimilar competition.
Key takeaways: savings from biosimilars are substantial, but take longer to accrue than commonly seen with generic small molecules.
1/
jamanetwork.com/journals/jam...